Raw material supplies usually sell a pre-diluted EGF solution and recommend adding roughly 1-5% of that solution to a formula
Our Final Thoughts The GLP-1 microdosing trend, while born from a desire for solutions, isnt without risk
But Wegovy may increase the risk of pancreatitis, gallbladder disease, severe gastrointestinal side effects that may lead to dehydration or kidney injury, increased heart rate, and suicidal thoughts or behaviors
Carrying excess weight puts stress on knees, hips, and other joints
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) mimic this hormone to slow gastric emptying, reducing appetite and curbing food cravings